The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review
IntroductionAlcohol use disorder (AUD) is the most prevalent substance use disorder (SUD) globally. In 2019, AUD affected 14.5 million Americans and contributed to 95,000 deaths, with an annual cost exceeding 250 billion dollars. Current treatment options for AUD have moderate therapeutic effects an...
Main Authors: | Charlotte E. Goldfine, Jeremiah J. Tom, Dana D. Im, Benjamin Yudkoff, Amit Anand, Joseph J. Taylor, Peter R. Chai, Joji Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1141836/full |
Similar Items
-
Hypomagnesemia in patients with chronic alcoholism in thecourse of alcohol withdrawal syndrome
by: V R Stasyukinene, et al.
Published: (2004-11-01) -
Protocol for a randomised controlled trial of cognitive bias modification training during inpatient withdrawal from alcohol use disorder
by: Victoria Manning, et al.
Published: (2018-11-01) -
Alterations in Oxidative Stress Status During Early Alcohol Withdrawal in Alcoholic Patients
by: Ming-Chyi Huang, et al.
Published: (2009-07-01) -
Clinical management of alcohol withdrawal: A systematic review
by: Shivanand Kattimani, et al.
Published: (2013-01-01) -
Trends in pharmacotherapy selection for the treatment of alcohol withdrawal in the Free State Province, South Africa
by: Paulina M van Zyl, et al.
Published: (2013-11-01)